CRISPR-crafted mouse model of rare TPI deficiency enables mechanistic studies and therapeutic exploration for this childhood neurodegenerative disorder.
Novel AMPK activators block ubiquitin-mediated degradation, boosting AMPK levels with nanomolar potency for metabolic, inflammatory, and cancer therapies.
Integrated multimedia system automatically tracks food intake and activity, generating clinician-ready reports for personalized care and self-management.
